公司資料
23andMe 股價、新聞與催化劑
- 股票代碼:
- ME
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for ME.
公司概覽
業務概覽
23andMe is a consumer genetics and research company built around genetic testing, data services, and health-related insights. Its model is rooted in consumer engagement more than drug development.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, 23andMe sits in consumer genetics and health data.
商業模式特徵
The business depends on consumer subscriptions, data monetization, and the ability to turn genetics into recurring value.
生技產業定位
23andMe is outside biotech proper and is better viewed as a consumer genetics and health-data platform.
未來催化劑
- 23andMe's catalysts are asset sales, balance-sheet actions, and any move that clarifies how consumer genetics and data fit into the next business model. The company is now more of a restructuring story than a growth story.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。